Articles

There has been an error retrieving the data. Please try again.

Regulators of TRAIL in breast cancer

Novel molecular regulators of the tumor necrosis factor-related apoptosis inducing ligand (TRAIL) pathway in breast cancer cells were identified, suggesting their role in combination with TRAIL as potential therapeutic targets for breast cancer.

MTR: a breast cancer risk factor

Mammographic texture resemblance (MTR) is validated as an independent risk factor for breast cancer, following two study cohorts indicating elevated risk despite differences in x-ray technology, population demographics, follow up time and geography.

Aspirin and breast cancer survival

There is little evidence of an association between low-dose aspirin usage and breast cancer-specific survival in a cohort of newly diagnosed breast cancer patients from the UK Clinical Practice Research Datalink.

Status of adjuvant endocrine therapy

Smith and Schiavon review adjuvant endocrine therapy for hormone receptor-positive early breast cancer, discussing how extended therapy for selected patients with tamoxifen or an aromatase inhibitor (AI) further reduces risk of relapse.

View original post here:
Breast Cancer Research

Comments are closed.